| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000124915.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000152931.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000163597.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000168367.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000170590.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000172965.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000177738.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000177757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000177757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000178193.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000178412.4 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000178440.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000178977.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000179818.9 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000180846.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000182376.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000183822.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000184274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000186594.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000186615.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000186615.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000196559.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000196756.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000197332.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203307.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203321.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203325.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203362.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203362.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203441.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203496.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203496.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203865.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203875.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000203999.4 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000204011.4 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000204054.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000204055.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000204362.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000204380.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000204929.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000205041.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000205500.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000205611.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000206195.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000212163.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000212663.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000212939.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000213793.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000214353.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000214353.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000214719.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000214770.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000214851.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000215159.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000215304.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000215447.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000215863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000215863.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000215908.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000217258.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000220161.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000222041.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223387.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223396.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223401.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223461.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223571.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223579.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223685.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223759.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223768.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223779.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000223882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224043.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224078.8 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224078.8 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224189.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224269.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224535.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224536.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224596.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224649.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224687.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224745.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224745.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224761.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224764.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224790.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000224934.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225037.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225057.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225057.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225075.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225096.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225113.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225205.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225231.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225234.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225315.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225527.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225579.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225632.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225676.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225750.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225767.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225806.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225806.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225891.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225956.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000225975.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226029.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226137.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226155.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226276.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226335.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226381.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226416.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226471.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226505.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226562.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226637.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226649.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226674.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226688.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226756.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226853.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226862.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226869.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227017.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227017.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227036.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227060.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227070.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227110.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227155.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227165.3 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227192.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227195.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227256.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227373.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227373.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227415.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227527.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227617.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227619.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227698.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227733.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227773.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227848.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000227917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228060.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228065.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228084.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228126.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228150.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228203.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228323.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228340.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228352.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228363.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228369.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228386.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228404.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228661.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228661.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228679.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228701.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228742.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228742.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228775.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228784.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228791.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228801.5 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228812.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228817.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228817.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228826.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228839.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000228886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229021.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229152.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229291.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229348.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229348.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229368.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229404.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229463.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229539.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229660.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229697.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229723.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229728.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229739.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229832.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229955.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229989.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000229999.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230065.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230124.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230155.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230289.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230534.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230587.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230613.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230630.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230648.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230724.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230806.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230817.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230896.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000230896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231023.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231104.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231104.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231134.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231242.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231249.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231290.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231305.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231329.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231459.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231527.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231563.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231599.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231628.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231646.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231734.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231734.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231734.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231760.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231769.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231816.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231865.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231871.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231890.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231896.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000231993.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232063.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232086.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232098.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232117.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232118.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232151.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232300.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232311.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232336.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232347.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232442.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232490.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232519.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232533.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232545.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232586.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232623.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232640.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232642.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232710.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232712.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232721.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232754.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232934.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232956.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000232977.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233101.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233154.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233178.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233368.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233509.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233547.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233547.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233613.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233627.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233695.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233797.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233806.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233901.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000233953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234019.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234197.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234232.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234252.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234281.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234290.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234432.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234535.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234617.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234684.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234698.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234722.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234807.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234807.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234869.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234912.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000234917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235052.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235079.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235106.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235117.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235138.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235244.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235246.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235298.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235314.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235387.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235419.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235423.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235423.4 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235501.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235609.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235609.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235652.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235726.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235740.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235781.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235802.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235806.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235831.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235890.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235954.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235979.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000235999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236188.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236209.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236337.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236438.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236438.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236463.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236514.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236514.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236526.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236546.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236617.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236618.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236753.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236772.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236830.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000236961.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237094.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237187.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237280.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237291.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237301.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237357.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237357.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237461.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237489.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237491.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237505.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237505.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237520.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237845.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237883.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237903.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000237975.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238005.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238035.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238039.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238045.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238113.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238178.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238186.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238198.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000238279.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000239415.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000239569.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000239906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000239906.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000239911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240057.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240211.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240498.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240571.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240859.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240875.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000240922.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000241219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000241570.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000241599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242190.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242207.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242357.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242553.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242759.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000242797.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243176.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243415.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243636.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243766.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243766.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243795.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243960.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000243967.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000244030.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000244055.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000244124.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000244393.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000244393.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000244459.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000244468.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245248.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245248.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245468.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245479.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245571.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245685.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245904.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245910.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000245937.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000246089.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000246090.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000246548.3 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000246863.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247011.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247137.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247345.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247373.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247400.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000247774.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248049.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248103.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248112.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248223.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248228.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248266.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248318.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248416.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248479.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248514.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248607.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248714.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248774.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248810.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248858.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000248896.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249451.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249502.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249592.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249593.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249746.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249753.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249807.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249846.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249870.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000249996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250132.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250133.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250155.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250156.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250241.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250282.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250286.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250302.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250312.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250312.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250326.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250404.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250802.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000250999.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251018.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251072.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251161.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251323.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251413.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251432.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251461.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251555.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000251661.3 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253133.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253307.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253385.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253390.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253508.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253522.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253552.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253642.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253649.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253678.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253730.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253829.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253848.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253877.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253878.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253898.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000253955.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254099.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254144.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254154.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254211.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254248.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254267.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254275.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254340.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254353.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254480.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254538.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254606.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254664.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254694.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254703.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254703.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254756.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254837.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254855.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254859.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000254966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255045.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255045.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255050.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255120.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255129.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255135.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255148.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255176.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255229.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255310.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255313.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255326.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255343.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255348.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255355.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255409.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255421.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255487.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255507.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255557.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255670.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255857.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000255980.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256139.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256234.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256458.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256576.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256789.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256897.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000256995.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257264.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257264.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257285.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257381.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257475.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257702.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257735.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257742.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257769.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257817.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257829.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000257894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258001.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258057.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258096.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258199.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258279.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258301.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258302.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258302.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258443.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258454.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258458.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258515.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258526.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258561.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258561.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258592.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258704.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258752.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258821.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258857.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258857.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000258940.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259135.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259172.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259245.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259248.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259290.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259294.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259298.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259349.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259364.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259380.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259418.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259424.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259439.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259532.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259548.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259595.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259606.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259617.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259656.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259687.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259709.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259782.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259792.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259796.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259799.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259826.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259867.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259887.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259953.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000259994.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260018.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260077.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260288.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260316.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260366.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260417.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260439.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260464.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260552.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260552.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260604.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260625.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260637.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260660.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260671.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260671.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260672.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260719.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260733.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260743.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260743.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260805.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260833.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260841.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260924.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260929.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260988.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000260992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261051.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261064.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261068.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261114.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261114.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261124.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261131.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261141.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261159.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261168.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261216.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261220.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261222.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261267.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261269.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261270.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261291.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261369.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261428.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261437.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261438.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261441.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261451.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261451.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261471.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261474.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261512.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261560.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261572.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261644.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261654.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261656.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261673.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261690.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261692.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261695.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261760.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261773.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261799.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261888.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261916.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261916.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000261916.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262147.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262313.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262372.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262678.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262678.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262692.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262692.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262766.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262837.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262837.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262944.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000262952.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263004.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263063.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263105.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263300.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263325.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263466.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263466.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263466.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263531.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263624.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263680.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263753.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263860.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263931.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264107.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264304.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264304.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264365.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264456.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264513.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264575.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264745.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264829.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264829.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264895.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000264940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265055.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265206.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265334.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265394.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265443.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265458.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265625.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265666.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265688.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265692.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265750.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265787.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265800.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265845.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265845.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265908.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000265933.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266079.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266236.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266261.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266283.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266304.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266473.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266521.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266538.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266538.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266604.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266654.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266677.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266805.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266912.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266922.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266933.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000266947.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267002.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267025.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267025.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267080.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267104.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267174.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267213.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267219.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267222.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267232.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267259.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267272.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267296.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267325.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267345.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267374.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267381.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267395.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267416.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267432.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267475.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267501.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267505.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267505.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267537.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267546.2 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267563.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267568.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267682.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267682.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267709.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267715.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267715.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267731.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267759.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267786.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267852.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000267874.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268061.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268061.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268087.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268189.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268199.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268201.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268471.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268496.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268530.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268573.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268658.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000268945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269044.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269054.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269386.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269386.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269423.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269425.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269425.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269444.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269463.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269486.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269574.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269737.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269843.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269918.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269924.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269924.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269961.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269971.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000269983.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270018.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270020.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270041.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270041.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270066.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270066.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270069.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270104.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270130.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270164.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270165.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270184.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270346.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270589.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270605.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270681.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270681.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270704.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270750.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270820.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270883.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000270949.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271151.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271199.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271208.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271228.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271554.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271576.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271590.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271631.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271755.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271755.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271771.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271778.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271788.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271843.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271871.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271888.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271916.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000271998.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272005.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272023.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272057.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272077.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272102.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272112.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272146.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272216.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272239.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272288.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272312.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272328.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272341.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272354.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272375.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272389.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272416.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272459.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272463.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272463.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272489.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272505.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272508.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272512.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272518.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272525.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272622.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272631.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272650.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272690.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272692.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272709.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272715.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272716.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272745.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272760.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272764.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272769.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272780.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272784.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272784.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272792.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272795.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272795.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272796.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272800.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272824.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272829.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272870.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272871.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272872.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272885.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272888.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272908.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272911.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272940.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272940.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272970.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272977.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000272983.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273009.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273017.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273035.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273058.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273061.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273071.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273116.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273117.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273117.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273133.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273162.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273181.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273240.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273253.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273267.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273281.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273305.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273321.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273344.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273355.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273368.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273375.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273381.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273461.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273483.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| 8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid |
ENSG00000273486.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
